Orobit Eye Drops (Ofloxacin)

Adult eye dose

Instill (apply) 1 drop 3 times daily. The dose may be adjusted according to symptoms.

This drug should not be used in patients with a hypersensitivity to quinolone antibiotics. During use, symptoms of shock such as nausea, limb coldness, and difficulty breathing may rarely occur. If such symptoms arise, use should be discontinued immediately and proper treatment should be sought. Hypersensitivity reactions may include cardiovascular collapse, loss of consciousness, angioedema, airway obstruction, difficulty breathing, rash, hives, itching, periorbital redness, and swelling. If these symptoms occur, medication should be stopped. There may be temporary burning, irritation, or discomfort in the eye, which may occasionally include pain, redness, itching, chemical conjunctivitis, keratitis, glare, blurred vision, tearing, dryness, and ocular pain. Rarely, dizziness or corneal disorders may occur, and in severe cases, it can worsen to Stevens-Johnson syndrome, so medication should be stopped immediately if these symptoms develop. Hearing impairment or irritation may occur, so caution is advised. To prevent the emergence of resistant bacteria, this drug should only be used for the minimum necessary duration after confirming susceptibility, and long-term use should be avoided due to the risk of excessive proliferation of fungi or resistant bacteria. For trachoma treatment, a basic treatment period of 8 weeks is recommended, after which further treatment should be carefully considered. During treatment, patients using preparations that contain benzalkonium chloride should avoid wearing soft contact lenses. Women who are pregnant or may become pregnant should only use this drug when the benefits of treatment outweigh the risks, as its safety has not been established. During lactation, discontinuation of the medication or breastfeeding is recommended. It is advisable not to use this drug in infants under the age of 1 year, as safety and efficacy have not been confirmed. This drug is for ophthalmic use only; care should be taken to avoid letting the tip of the container touch the eye directly. To prevent contamination, it is advisable to avoid sharing the product if possible. When storing, keep it out of reach of children, avoid direct sunlight, and store it in a cool, dry place. Do not transfer the medication to another container, and to prevent misuse and maintain quality, it is crucial to keep it in its original container.

• Nausea
• peripheral coldness
• dyspnea
• cardiovascular collapse
• loss of consciousness
• angioedema (pharynx, larynx, face)
• airway obstruction
• rash
• urticaria
• pruritus

This drug may be sensitive to air or moisture, so it should always be stored in a sealed container. It is also best to avoid storing it in extremely hot or cold environments, ideally at room temperature between 1 and 30 degrees Celsius.

Appearance

A transparent solution ranging from pale yellow to yellow, in a colorless transparent plastic container.

Package unit

6mL/bottle